2021
DOI: 10.1128/aac.01146-21
|View full text |Cite
|
Sign up to set email alerts
|

Candida aurisInvasive Infections during a COVID-19 Case Surge

Abstract: Clinical cases of C. auris noted during a COVID-19 surge led to an epidemiological, clinical, and genomic investigation. Evaluation identified a close genetic relationship but no conclusive epidemiologic link between all cases. Prolonged hospitalization due to critical illness from COVID-19 and use of antimicrobials may have contributed to clinical infections.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
40
0
2

Year Published

2021
2021
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 53 publications
(42 citation statements)
references
References 7 publications
0
40
0
2
Order By: Relevance
“…Among the opportunistic infections in COVID-19 patients, a higher incidence of fungal co-infections was observed [112][113][114][115]. Most fungalrelated co-infections in COVID-19 patients involved Aspergillus spp., C. albicans, C. auris, C. dubliniensis, C. glabrata, C. tropicalis, C. krusei, and C. parapsilosis sensu stricto [116,117].…”
Section: Candida and Other Fungal Infections In Covid-19mentioning
confidence: 99%
“…Among the opportunistic infections in COVID-19 patients, a higher incidence of fungal co-infections was observed [112][113][114][115]. Most fungalrelated co-infections in COVID-19 patients involved Aspergillus spp., C. albicans, C. auris, C. dubliniensis, C. glabrata, C. tropicalis, C. krusei, and C. parapsilosis sensu stricto [116,117].…”
Section: Candida and Other Fungal Infections In Covid-19mentioning
confidence: 99%
“…Outbreaks of Candida auris have been reported post-COVID-19 in many countries including four South American countries and Arab countries such as Lebanon where this fungus had never been isolated in the pre-COVID-19 era [ 63 ]. This is likely due to overconsumption of antimicrobial agents, particularly antifungal drugs, as well as poor infection control practices during the pandemic [ 63 , 64 , 65 , 66 ]. More recently, mucormycosis has emerged as an important and deadly co-infection in India and some countries of the Americas [ 67 ].…”
Section: The Covid-19 Pandemic: What Do We Know?mentioning
confidence: 99%
“…Critically-ill COVID-19 patients with ARDS are also reported to be more susceptible to fungal super-infections caused by Candida species and Aspergillus fumigatus . 7 , 8 Invasion of internal organs by Candida species might occur in patients with severe COVID-19 due to excessive use of antibiotics and corticosteroids, and central venous catheter, coupled with the complications caused by severe ARDS coronavirus 2 (SARS CoV-2). 9 Besides candidiasis and aspergillosis, occurrence of mucormycosis (also known as “black fungus”) has been reported recently in Asian countries (mostly in India) among patients affected with COVID-19.…”
Section: Introductionmentioning
confidence: 99%